niacinamide has been researched along with Elephantiasis Neuromatosis in 2 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sorafenib was administered orally twice daily for consecutive 28-day cycles." | 2.78 | Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas. ( Balis, FM; Choyke, PL; Dombi, E; Fox, E; Jayaprakash, N; Kim, A; Korf, B; Martin, S; Muradyan, N; Reddy, A; Tepas, K; Turkbey, B; Widemann, BC; Wolters, P, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wu, J | 1 |
| Dombi, E | 2 |
| Jousma, E | 1 |
| Scott Dunn, R | 1 |
| Lindquist, D | 1 |
| Schnell, BM | 1 |
| Kim, MO | 1 |
| Kim, A | 2 |
| Widemann, BC | 2 |
| Cripe, TP | 1 |
| Ratner, N | 1 |
| Tepas, K | 1 |
| Fox, E | 1 |
| Martin, S | 1 |
| Wolters, P | 1 |
| Balis, FM | 1 |
| Jayaprakash, N | 1 |
| Turkbey, B | 1 |
| Muradyan, N | 1 |
| Choyke, PL | 1 |
| Reddy, A | 1 |
| Korf, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase II Study of Binimetinib in Children and Adults With NF1 Associated Plexiform Neurofibromas (PNOC010)[NCT03231306] | Phase 2 | 40 participants (Anticipated) | Interventional | 2017-11-28 | Active, not recruiting | ||
| Developing Novel Biomarkers of Plexiform Neurofibroma Tumor Burden[NCT05238909] | 200 participants (Anticipated) | Observational [Patient Registry] | 2022-03-04 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for niacinamide and Elephantiasis Neuromatosis
| Article | Year |
|---|---|
Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.
Topics: Adolescent; Antineoplastic Agents; Child; Child, Preschool; Female; Humans; Male; Maximum Tolerated | 2013 |
1 other study available for niacinamide and Elephantiasis Neuromatosis
| Article | Year |
|---|---|
Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.
Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Blotting, Western; Cell Proliferation; Chromatogr | 2012 |
Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.
Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Blotting, Western; Cell Proliferation; Chromatogr | 2012 |
Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.
Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Blotting, Western; Cell Proliferation; Chromatogr | 2012 |
Preclincial testing of sorafenib and RAD001 in the Nf(flox/flox) ;DhhCre mouse model of plexiform neurofibroma using magnetic resonance imaging.
Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Blotting, Western; Cell Proliferation; Chromatogr | 2012 |